Anmeldung Registrierung
Auto Hell Dunkel
Erweiterte Suche
  1. Startseite
  2. Podcasts
  3. Medizin - Open Access LMU - Teil 13/22 Podcast
  4. Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial
Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial

Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial

Zu Sammlung hinzufügen

Du hast noch keine Sammlungen.

Herunterladen (rechte Maustaste) Teilen Fundstellen Kommentare
0:00
0:00
Background: Diabetic dyslipoproteinemia is characterized by
hypertriglyceridemia, low HDL-cholesterol and often elevated
LDL-cholesterol and is a strong risk factor for atherosclerosis.
Adhesion molecule levels are elevated both in hyperlipoproteinemia
and diabetes mellitus. It is unclear whether fibrate or statin
therapy has more beneficial effects on adhesion molecule
concentrations. Methods: Atorvastatin (10 mg/d) was compared to
fenofibrate (200 mg/d) each for 6 weeks separated by a 6 week
washout period in 11 patients (6 male, 5 female; 61.8 +/- 8.2
years; body mass index 29.8 +/- 3.1 kg/m(2)) with type 2 diabetes
mellitus (HbA(1c) 7.3 +/- 1.1 %) and mixed hyperlipoproteinemia
using a randomized, cross-over design. Fasting blood glucose,
HbA(1)c, lipid parameters, E-selectin, ICAM-1, VCAM-1, and
fibrinogen concentrations were determined before and after each
drug. Results: Glucose and HbA(1)c concentrations remained
unchanged during the whole study period. LDL cholesterol was
reduced during atorvastatin therapy, triglycerides were lowered
more effectively with fenofibrate. Comparison of pre- and
postreatment concentrations of E-selectin showed a reduction during
atorvastatin (-7 %, p = 0.11) and fenofibrate (-10 %, p < 0.05)
therapy. Atorvastatin treatment reduced VCAM-1 levels by 4% (p <
0.05), while VCAM-1 concentrations remained unchanged (+1%, ns)
during fenofibate therapy. However, direct comparisons of
posttreatment levels during both forms of therapy were not of
statistical significance. ICAM-1 levels were not influenced by
either form of therapy. Conclusions: In addition to the different
beneficial effects on lipid metabolism, both drugs appear to lower
adhesion molecule plasma concentrations in a different manner in
patients with type 2 diabetes and mixed hyperlipoproteinemia. Our
observations should be confirmed in a larger cohort of such
patients.
Episode melden

„Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial“

Worum geht es? Danach fragen wir noch nach dem Grund.

Abonnenten

Teilen

Mein Archiv

Deine Privatkopie der Folgen, die du nicht verlieren willst.

Podcast-Folgen verschwinden. Feeds werden auf die letzten Episoden gekürzt, Hoster räumen alte Dateien ab, Formate wechseln den Anbieter und lassen ihr Archiv zurück. Mit „Mein Archiv“ sichert podcast.de die Folgen deiner Podcasts für dich — angefangen bei den ältesten, denn die sind zuerst weg.

  • Deine gesicherten Folgen bleiben hörbar, auch wenn das Original offline geht.
  • Auch Folgen, die im heutigen Feed gar nicht mehr stehen — podcast.de kennt sie noch.
  • Herunterladen bleibt möglich, solange die Folge beim Podcaster liegt. Der zählt seine Abrufe wie bisher.
Startet bald

Sei beim Start von Mein Archiv dabei

Mein Archiv ist fast fertig. Trag dich ein, dann bekommst du eine E-Mail, sobald es losgeht – und bist von Anfang an dabei. Wir schreiben dir nur zum Start, keine Werbung, keine Weitergabe deiner Daten.

Du bekommst zuerst eine Bestätigungsmail. Abmelden geht jederzeit. Datenschutz